Related Articles
Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis
Parthenolide induces apoptosis in colitis-associated colon cancer, inhibiting NF-κB signaling
Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer
Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer
Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer